Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 132

1.

Correction to: Clinical risk factors of stroke and major bleeding in patients with non-valvular atrial fibrillation under rivaroxaban: the EXPAND Study sub-analysis.

Sakuma I, Uchiyama S, Atarashi H, Inoue H, Kitazono T, Yamashita T, Shimizu W, Ikeda T, Kamouchi M, Kaikita K, Fukuda K, Origasa H, Shimokawa H.

Heart Vessels. 2019 Nov;34(11):1852-1857. doi: 10.1007/s00380-019-01479-x.

2.

Clinical risk factors of stroke and major bleeding in patients with non-valvular atrial fibrillation under rivaroxaban: the EXPAND Study sub-analysis.

Sakuma I, Uchiyama S, Atarashi H, Inoue H, Kitazono T, Yamashita T, Shimizu W, Ikeda T, Kamouchi M, Kaikita K, Fukuda K, Origasa H, Shimokawa H.

Heart Vessels. 2019 Nov;34(11):1839-1851. doi: 10.1007/s00380-019-01425-x. Epub 2019 May 24. Erratum in: Heart Vessels. 2019 Aug 2;:.

3.

Poor glycemic control and posterior circulation ischemic stroke.

Kuroda J, Matsuo R, Yamaguchi Y, Sato N, Kamouchi M, Hata J, Wakisaka Y, Ago T, Kitazono T; Fukuoka Stroke Registry Investigators.

Neurol Clin Pract. 2019 Apr;9(2):129-139. doi: 10.1212/CPJ.0000000000000608.

PMID:
31041127
4.

Association of Embolic Sources With Cause-Specific Functional Outcomes Among Adults With Cryptogenic Stroke.

Kiyuna F, Sato N, Matsuo R, Kamouchi M, Hata J, Wakisaka Y, Kuroda J, Ago T, Kitazono T; Fukuoka Stroke Registry Investigators.

JAMA Netw Open. 2018 Sep 7;1(5):e182953. doi: 10.1001/jamanetworkopen.2018.2953.

5.

Primary and secondary prevention of stroke and systemic embolism with rivaroxaban in patients with non-valvular atrial fibrillation : Sub-analysis of the EXPAND Study.

Uchiyama S, Atarashi H, Inoue H, Kitazono T, Yamashita T, Shimizu W, Ikeda T, Kamouchi M, Kaikita K, Fukuda K, Origasa H, Shimokawa H.

Heart Vessels. 2019 Jan;34(1):141-150. doi: 10.1007/s00380-018-1219-0. Epub 2018 Jul 6.

6.

Insulin resistance and clinical outcomes after acute ischemic stroke.

Ago T, Matsuo R, Hata J, Wakisaka Y, Kuroda J, Kitazono T, Kamouchi M; Fukuoka Stroke Registry Investigators.

Neurology. 2018 Apr 24;90(17):e1470-e1477. doi: 10.1212/WNL.0000000000005358. Epub 2018 Mar 30.

PMID:
29602916
7.

Safety of antithrombotic therapy for patients with acute ischemic stroke harboring unruptured intracranial aneurysm.

Shono Y, Sugimori H, Matsuo R, Fukushima Y, Wakisaka Y, Kuroda J, Ago T, Kamouchi M, Kitazono T.

Int J Stroke. 2018 Oct;13(7):734-742. doi: 10.1177/1747493018765263. Epub 2018 Mar 15.

PMID:
29543141
8.

The EXPAND study: Efficacy and safety of rivaroxaban in Japanese patients with non-valvular atrial fibrillation.

Shimokawa H, Yamashita T, Uchiyama S, Kitazono T, Shimizu W, Ikeda T, Kamouchi M, Kaikita K, Fukuda K, Origasa H, Sakuma I, Saku K, Okumura Y, Nakamura Y, Morimoto H, Matsumoto N, Tsuchida A, Ako J, Sugishita N, Shimizu S, Atarashi H, Inoue H.

Int J Cardiol. 2018 May 1;258:126-132. doi: 10.1016/j.ijcard.2018.01.141. Epub 2018 Feb 3.

9.

Association Between Onset-to-Door Time and Clinical Outcomes After Ischemic Stroke.

Matsuo R, Yamaguchi Y, Matsushita T, Hata J, Kiyuna F, Fukuda K, Wakisaka Y, Kuroda J, Ago T, Kitazono T, Kamouchi M; Fukuoka Stroke Registry Investigators.

Stroke. 2017 Nov;48(11):3049-3056. doi: 10.1161/STROKEAHA.117.018132. Epub 2017 Oct 3.

PMID:
28974631
10.

Association between the maximal distance of atrial septal protrusion and cryptogenic stroke.

Tokunaga K, Yasaka M, Kuwashiro T, Gotoh S, Nakamura A, Takaguchi G, Ago T, Kamouchi M, Kitazono T, Okada Y.

Int J Stroke. 2017 Dec;12(9):941-945. doi: 10.1177/1747493016685721. Epub 2016 Dec 20.

PMID:
28885101
11.

Erratum to: Rationale and design of oBservational clinical Research In chronic kidney disease patients with renal anemia: renal proGnosis in patients with Hyporesponsive anemia To Erythropoiesis-stimulating agents, darbepoetiN alfa (BRIGHTEN Trial).

Kato H, Nangaku M, Hirakata H, Wada T, Hayashi T, Sato H, Yamazaki Y, Masaki T, Kagimura T, Yamamoto H, Hase H, Kamouchi M, Imai E, Mizuno K, Iwasaki M, Akizawa T, Tsubakihara Y, Maruyama S, Narita I.

Clin Exp Nephrol. 2018 Feb;22(1):85-86. doi: 10.1007/s10157-017-1461-2. No abstract available.

PMID:
28875480
12.

Left Atrial Size and Long-Term Risk of Recurrent Stroke After Acute Ischemic Stroke in Patients With Nonvalvular Atrial Fibrillation.

Ogata T, Matsuo R, Kiyuna F, Hata J, Ago T, Tsuboi Y, Kitazono T, Kamouchi M; FSR Investigators.

J Am Heart Assoc. 2017 Aug 15;6(8). pii: e006402. doi: 10.1161/JAHA.117.006402.

13.

Rationale and design of oBservational clinical Research In chronic kidney disease patients with renal anemia: renal proGnosis in patients with Hyporesponsive anemia To Erythropoiesis-stimulating agents, darbepoetiN alfa (BRIGHTEN Trial).

Kato H, Nangaku M, Hirakata H, Wada T, Hayashi T, Sato H, Yamazaki Y, Masaki T, Kagimura T, Yamamoto H, Hase H, Kamouchi M, Imai E, Mizuno K, Iwasaki M, Akizawa T, Tsubakihara Y, Maruyama S, Narita I.

Clin Exp Nephrol. 2018 Feb;22(1):78-84. doi: 10.1007/s10157-017-1427-4. Epub 2017 Jun 28. Erratum in: Clin Exp Nephrol. 2017 Sep 5;:.

14.

Optimal Anticoagulation for Patients With Atrial Fibrillation - Benefits for Reducing Stroke Severity.

Kamouchi M.

Circ J. 2017 Feb 24;81(3):306-307. doi: 10.1253/circj.CJ-17-0039. Epub 2017 Jan 31. No abstract available.

15.

Timing of Anticoagulant Therapy After Acute Ischemic Stroke.

Matsuo R, Kamouchi M.

Circ J. 2017 Jan 25;81(2):151-152. doi: 10.1253/circj.CJ-16-1287. Epub 2016 Dec 28. No abstract available.

16.

Adverse Influence of Pre-Stroke Dementia on Short-Term Functional Outcomes in Patients with Acute Ischemic Stroke: The Fukuoka Stroke Registry.

Wakisaka Y, Matsuo R, Hata J, Kuroda J, Kitazono T, Kamouchi M, Ago T; Fukuoka Stroke Registry Investigators.

Cerebrovasc Dis. 2017;43(1-2):82-89. doi: 10.1159/000453625. Epub 2016 Dec 10.

PMID:
27951543
17.

Study Design and Baseline Characteristics of the EXPAND Study: Evaluation of Effectiveness and Safety of Xa Inhibitor, Rivaroxaban for the Prevention of Stroke and Systemic Embolism in a Nationwide Cohort of Japanese Patients Diagnosed as Non-Valvular Atrial Fibrillation.

Ikeda T, Atarashi H, Inoue H, Uchiyama S, Kitazono T, Yamashita T, Shimizu W, Kamouchi M, Kaikita K, Fukuda K, Origasa H, Sakuma I, Saku K, Okumura Y, Nakamura Y, Morimoto H, Matsumoto N, Tsuchida A, Ako J, Sugishita N, Shimizu S, Shimokawa H.

Tohoku J Exp Med. 2016 Dec;240(4):259-268.

18.

Short-Term Exposure to Fine Particulate Matter and Risk of Ischemic Stroke.

Matsuo R, Michikawa T, Ueda K, Ago T, Nitta H, Kitazono T, Kamouchi M; Fukuoka Stroke Registry Investigators.

Stroke. 2016 Dec;47(12):3032-3034. Epub 2016 Nov 3.

PMID:
27811333
19.

Anti-Cyclic Citrullinated Peptide Antibody-Positive Meningoencephalitis in the Preclinical Period of Rheumatoid Arthritis.

Shibahara T, Matsushita T, Matsuo R, Fukushima Y, Fukuda K, Sugimori H, Kamouchi M, Kitazono T, Ago T.

Case Rep Neurol. 2016 Jul 20;8(2):156-160. eCollection 2016 May-Aug.

20.

An association between fine particulate matter (PM2.5) levels and emergency ambulance dispatches for cardiovascular diseases in Japan.

Ichiki T, Onozuka D, Kamouchi M, Hagihara A.

Int Arch Occup Environ Health. 2016 Nov;89(8):1329-1335. Epub 2016 Sep 10.

PMID:
27614747
21.

Impaired Swallowing in Hospitalized Patients: An Observational Study in a Community Hospital in Japan (2012-2014).

Hayashi M, Yahiro A, Sakuragi Y, Iwamatsu K, Sakamoto H, Kaizuka Y, Tsuchihashi T, Kamouchi M.

Nurs Res. 2016 Sep-Oct;65(5):389-96. doi: 10.1097/NNR.0000000000000178.

PMID:
27579506
22.

Influence of Statin Pretreatment on Initial Neurological Severity and Short-Term Functional Outcome in Acute Ischemic Stroke Patients: The Fukuoka Stroke Registry.

Ishikawa H, Wakisaka Y, Matsuo R, Makihara N, Hata J, Kuroda J, Ago T, Kitayama J, Nakane H, Kamouchi M, Kitazono T; Fukuoka Stroke Registry Investigators.

Cerebrovasc Dis. 2016;42(5-6):395-403. Epub 2016 Jul 5.

PMID:
27376661
23.

Plasma C-Reactive Protein and Clinical Outcomes after Acute Ischemic Stroke: A Prospective Observational Study.

Matsuo R, Ago T, Hata J, Wakisaka Y, Kuroda J, Kuwashiro T, Kitazono T, Kamouchi M; Fukuoka Stroke Registry Investigators.

PLoS One. 2016 Jun 3;11(6):e0156790. doi: 10.1371/journal.pone.0156790. eCollection 2016.

24.

Causes of Ischemic Stroke in Patients with Non-Valvular Atrial Fibrillation.

Nakamura A, Kuroda J, Ago T, Hata J, Matsuo R, Arakawa S, Kuwashiro T, Yasaka M, Okada Y, Kitazono T, Kamouchi M; Fukuoka Stroke Registry Investigators.

Cerebrovasc Dis. 2016;42(3-4):196-204. doi: 10.1159/000445723. Epub 2016 Apr 26.

PMID:
27111222
25.

Possible involvement of basic FGF in the upregulation of PDGFRβ in pericytes after ischemic stroke.

Nakamura K, Arimura K, Nishimura A, Tachibana M, Yoshikawa Y, Makihara N, Wakisaka Y, Kuroda J, Kamouchi M, Ooboshi H, Kitazono T, Ago T.

Brain Res. 2016 Jan 1;1630:98-108. doi: 10.1016/j.brainres.2015.11.003. Epub 2015 Nov 10.

PMID:
26569132
26.

Aortic Dissection as a Possible Underlying Cause of Acute Ischemic Stroke.

Kamouchi M.

Circ J. 2015;79(8):1697-8. doi: 10.1253/circj.CJ-15-0683. Epub 2015 Jul 8. No abstract available.

27.

Cerebral Small-Vessel Disease in Neuro-Behçet Disease.

Yoshimura S, Ago T, Koga M, Kamouchi M, Kitazono T.

J Stroke Cerebrovasc Dis. 2015 Aug;24(8):e237-9. doi: 10.1016/j.jstrokecerebrovasdis.2015.05.012. Epub 2015 Jun 27.

PMID:
26123875
28.

Day-by-Day Blood Pressure Variability and Functional Outcome After Acute Ischemic Stroke: Fukuoka Stroke Registry.

Fukuda K, Kai H, Kamouchi M, Hata J, Ago T, Nakane H, Imaizumi T, Kitazono T; FSR Investigators; steering committee of the Fukuoka Stroke Registry included.

Stroke. 2015 Jul;46(7):1832-9. doi: 10.1161/STROKEAHA.115.009076. Epub 2015 Jun 11.

PMID:
26069262
29.

A CADASIL-Like Case with a Novel Noncysteine Mutation of the NOTCH3 Gene and Granular Deposits in the Renal Arterioles.

Nakamura K, Ago T, Tsuchimoto A, Noda N, Nakamura A, Ninomiya T, Uchiumi T, Tsuruya K, Kamouchi M, Ooboshi H, Kitazono T.

Case Rep Neurol Med. 2015;2015:431461. doi: 10.1155/2015/431461. Epub 2015 Mar 9.

30.

Effects of hydrochlorothiazide on oxidative stress and pulse pressure in hypertensive patients with chronic stroke: the EMINENT study.

Nakane H, Kamouchi M, Hata J, Ibayashi S, Kusuda K, Omae T, Nagao T, Ago T, Kitazono T; EMINENT Study Investigators.

Intern Med. 2015;54(6):573-7. doi: 10.2169/internalmedicine.54.2631.

31.

Nox4 is a major source of superoxide production in human brain pericytes.

Kuroda J, Ago T, Nishimura A, Nakamura K, Matsuo R, Wakisaka Y, Kamouchi M, Kitazono T.

J Vasc Res. 2014;51(6):429-38. doi: 10.1159/000369930. Epub 2015 Jan 22.

32.

Sex differences in short-term outcomes after acute ischemic stroke: the fukuoka stroke registry.

Irie F, Kamouchi M, Hata J, Matsuo R, Wakisaka Y, Kuroda J, Ago T, Kitazono T; FSR Investigators.

Stroke. 2015 Feb;46(2):471-6. doi: 10.1161/STROKEAHA.114.006739. Epub 2014 Dec 30.

PMID:
25550372
33.

Involvement of platelet-derived growth factor receptor β in fibrosis through extracellular matrix protein production after ischemic stroke.

Makihara N, Arimura K, Ago T, Tachibana M, Nishimura A, Nakamura K, Matsuo R, Wakisaka Y, Kuroda J, Sugimori H, Kamouchi M, Kitazono T.

Exp Neurol. 2015 Feb;264:127-34. doi: 10.1016/j.expneurol.2014.12.007. Epub 2014 Dec 13.

PMID:
25510317
34.

Intravenous thrombolysis with recombinant tissue plasminogen activator for ischemic stroke patients over 80 years old: the Fukuoka Stroke Registry.

Matsuo R, Kamouchi M, Fukuda H, Hata J, Wakisaka Y, Kuroda J, Ago T, Kitazono T; FSR Investigators.

PLoS One. 2014 Oct 16;9(10):e110444. doi: 10.1371/journal.pone.0110444. eCollection 2014.

35.

Gastrointestinal bleeding in acute ischemic stroke: recent trends from the fukuoka stroke registry.

Ogata T, Kamouchi M, Matsuo R, Hata J, Kuroda J, Ago T, Sugimori H, Inoue T, Kitazono T; Fukuoka Stroke Registry.

Cerebrovasc Dis Extra. 2014 Jul 22;4(2):156-64. doi: 10.1159/000365245. eCollection 2014 May.

36.

Significance of plasma adiponectin for diagnosis, neurological severity and functional outcome in ischemic stroke - Research for Biomarkers in Ischemic Stroke (REBIOS).

Kuwashiro T, Ago T, Kamouchi M, Matsuo R, Hata J, Kuroda J, Fukuda K, Sugimori H, Fukuhara M, Awano H, Isomura T, Suzuki K, Yasaka M, Okada Y, Kiyohara Y, Kitazono T.

Metabolism. 2014 Sep;63(9):1093-103. doi: 10.1016/j.metabol.2014.04.012. Epub 2014 May 2.

PMID:
24929894
37.

Plasma S100A12 is associated with functional outcome after ischemic stroke: Research for Biomarkers in Ischemic Stroke.

Wakisaka Y, Ago T, Kamouchi M, Kuroda J, Matsuo R, Hata J, Gotoh S, Isomura T, Awano H, Suzuki K, Fukuda K, Okada Y, Kiyohara Y, Ooboshi H, Kitazono T; REBIOS Investigators.

J Neurol Sci. 2014 May 15;340(1-2):75-9. doi: 10.1016/j.jns.2014.02.031. Epub 2014 Mar 4.

PMID:
24629476
38.

Magnetic resonance imaging in breath-hold divers with cerebral decompression sickness.

Matsuo R, Kamouchi M, Arakawa S, Furuta Y, Kanazawa Y, Kitazono T.

Case Rep Neurol. 2014 Jan 24;6(1):23-7. doi: 10.1159/000357169. eCollection 2014 Jan.

39.

Impact of the 1425G/A polymorphism of PRKCH on the recurrence of ischemic stroke: Fukuoka Stroke Registry.

Matsuo R, Ago T, Hata J, Kuroda J, Wakisaka Y, Sugimori H, Kitazono T, Kamouchi M; FSR Investigators.

J Stroke Cerebrovasc Dis. 2014 Jul;23(6):1356-61. doi: 10.1016/j.jstrokecerebrovasdis.2013.11.011. Epub 2014 Feb 15.

PMID:
24534126
40.

ABCD3 and ABCD3-I scores are superior to ABCD2 score in the prediction of short- and long-term risks of stroke after transient ischemic attack.

Kiyohara T, Kamouchi M, Kumai Y, Ninomiya T, Hata J, Yoshimura S, Ago T, Okada Y, Kitazono T; Fukuoka Stroke Registry Investigators.

Stroke. 2014 Feb;45(2):418-25. doi: 10.1161/STROKEAHA.113.003077. Epub 2013 Dec 12.

PMID:
24335223
41.

Thrombolytic therapy with intravenous recombinant tissue plasminogen activator in Japanese older patients with acute ischemic stroke: Fukuoka Stroke Registry.

Matsuo R, Kamouchi M, Ago T, Hata J, Shono Y, Kuroda J, Wakisaka Y, Sugimori H, Kitazono T; FSR investigators.

Geriatr Gerontol Int. 2014 Oct;14(4):954-9. doi: 10.1111/ggi.12205. Epub 2013 Dec 9.

PMID:
24320947
42.

Trends in the incidence and survival of intracerebral hemorrhage by its location in a Japanese community.

Gotoh S, Hata J, Ninomiya T, Hirakawa Y, Nagata M, Mukai N, Fukuhara M, Ikeda F, Shikata K, Kamouchi M, Kitazono T, Kiyohara Y.

Circ J. 2014;78(2):403-9. Epub 2013 Nov 23.

43.

Statins and the risks of stroke recurrence and death after ischemic stroke: the Fukuoka Stroke Registry.

Makihara N, Kamouchi M, Hata J, Matsuo R, Ago T, Kuroda J, Kuwashiro T, Sugimori H, Kitazono T; Fukuoka Stroke Registry Investigators.

Atherosclerosis. 2013 Dec;231(2):211-5. doi: 10.1016/j.atherosclerosis.2013.09.017. Epub 2013 Oct 1.

PMID:
24267228
44.

Predictive role of C reactive protein in stroke recurrence after cardioembolic stroke: the Fukuoka Stroke Registry.

Kuwashiro T, Sugimori H, Ago T, Kuroda J, Kamouchi M, Kitazono T; FSR Investigators (see appendix).

BMJ Open. 2013 Nov 14;3(11):e003678. doi: 10.1136/bmjopen-2013-003678.

45.

High blood pressure after acute ischemic stroke is associated with poor clinical outcomes: Fukuoka Stroke Registry.

Ishitsuka K, Kamouchi M, Hata J, Fukuda K, Matsuo R, Kuroda J, Ago T, Kuwashiro T, Sugimori H, Nakane H, Kitazono T; FSR Investigators.

Hypertension. 2014 Jan;63(1):54-60. doi: 10.1161/HYPERTENSIONAHA.113.02189. Epub 2013 Oct 14.

PMID:
24126175
46.

Intensity of anticoagulation and clinical outcomes in acute cardioembolic stroke: the Fukuoka Stroke Registry.

Nakamura A, Ago T, Kamouchi M, Hata J, Matsuo R, Kuroda J, Kuwashiro T, Sugimori H, Kitazono T; Fukuoka Stroke Registry Investigators.

Stroke. 2013 Nov;44(11):3239-42. doi: 10.1161/STROKEAHA.113.002523. Epub 2013 Aug 20.

PMID:
23963334
47.

Secular trends in cardiovascular disease and its risk factors in Japanese: half-century data from the Hisayama Study (1961-2009).

Hata J, Ninomiya T, Hirakawa Y, Nagata M, Mukai N, Gotoh S, Fukuhara M, Ikeda F, Shikata K, Yoshida D, Yonemoto K, Kamouchi M, Kitazono T, Kiyohara Y.

Circulation. 2013 Sep 10;128(11):1198-205. doi: 10.1161/CIRCULATIONAHA.113.002424. Epub 2013 Jul 31.

PMID:
23902756
48.

[Progression of right internal carotid artery stenosis in ischemic stroke patient with autoimmune polyglandular syndrome: A case report].

Kanazawa Y, Matsuo R, Fukushima Y, Fukuda K, Kamouchi M, Kitazono T.

Rinsho Shinkeigaku. 2013;53(7):531-5. Japanese.

PMID:
23892964
49.

Acute kidney injury and edaravone in acute ischemic stroke: the Fukuoka Stroke Registry.

Kamouchi M, Sakai H, Kiyohara Y, Minematsu K, Hayashi K, Kitazono T.

J Stroke Cerebrovasc Dis. 2013 Nov;22(8):e470-6. doi: 10.1016/j.jstrokecerebrovasdis.2013.05.018. Epub 2013 Jun 22.

PMID:
23800495
50.

Stroke features and management in patients with chronic kidney disease.

Kamouchi M.

Contrib Nephrol. 2013;179:92-9. doi: 10.1159/000346727. Epub 2013 May 3. Review.

PMID:
23652452

Supplemental Content

Loading ...
Support Center